Assessing Sarcopenia In Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy - A Case Series

被引：0
|
作者：
Newton, Robert Usher [1 ]
机构：
[1] Edith Cowan Univ, Joondalup, Australia
来源：
MEDICINE & SCIENCE IN SPORTS & EXERCISE | 2024年 / 56卷 / 10期
关键词：
D O I：
暂无
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
2923
引用
收藏
页码：1080 / 1080
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (05): : 623 - 624
  • [22] Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
    Shafa, Anousheh
    Watkins, A. Brooke
    McGree, Michaela E.
    Weroha, S. John
    Hendrickson, Andrea E. Wahner
    Block, Matthew S.
    Langstraat, Carrie L.
    McBane, Robert D.
    Bakkum-Gamez, Jamie N.
    Kumar, Amanika
    GYNECOLOGIC ONCOLOGY, 2023, 176 : 36 - 42
  • [23] NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY FOR ADVANCED-STAGE ENDOMETRIAL CANCER
    Khaldi, H.
    Alsayed, M. T.
    Al-Ansari, A.
    Abu-Jubara, M.
    Almalik, H.
    Alhyassat, S.
    Herod, J. J. O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A79 - A80
  • [24] Neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer
    Kartsiounis, Christos
    Mitsakis, Ioannis
    Boutis, Anastasios
    Triantafillidis, Efstathios
    Evangelinos, Dimitrios
    Andreadis, Charalambos
    Kellartzis, Argirios
    ANNALS OF ONCOLOGY, 2006, 17 : 175 - 175
  • [25] Residual ascites after neoadjuvant chemotherapy decreases treatment response and survival in patients with advanced-stage epithelial ovarian cancer
    Han, K. H.
    Kim, H. S.
    Song, Y. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 710 - 710
  • [26] Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy
    Lee, Jung-Yun
    Lee, Yong Jae
    Son, Joo-Hyuk
    Kim, Sunghoon
    Choi, Min Chul
    Suh, Dong Hoon
    Song, Jae-Yun
    Hong, Dae Gy
    Kim, Mi Kyung
    Kim, Jae-Hoon
    Chang, Suk-Joon
    JAMA SURGERY, 2023, 158 (11) : 1133 - 1140
  • [27] Clinical experience in chemotherapy treatment for advanced-stage ovarian cancer
    Dumitru, M.
    Fagarasanu, Monica
    Cezar, Cristina
    Badescu, S.
    Tudosa, Rodica
    Soloviev, D.
    Vartej, P.
    GINECO RO, 2009, 5 (04): : 252 - 256
  • [28] Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
    Aletti, Giovanni D.
    Long, Harry J.
    Podratz, Karl C.
    Cliby, William A.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (01) : 212 - 216
  • [29] Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?
    Al Mutairi, Nashmia
    Le, Tien
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2019, 41 (02) : 185 - 190
  • [30] Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease
    Ferron, Jean-Guillaume
    Uzan, Catherine
    Rey, Annie
    Gouy, Sebastien
    Pautier, Patricia
    Lhomme, Catherine
    Duvillard, Pierre
    Morice, Philippe
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 147 (01) : 101 - 105
12345